Lilly's profit grew
141% — and it's
spending billions to
make more.
The drugs are so in-demand the bottleneck is factories, not buyers.
↓ scroll to read
✦ The bottom line
Lilly's operating profit grew 141% to $8.9 billion on 82% gross margins. The catch: it's pouring billions into building factories, because it still can't make the shots fast enough.
↓ the brief below
✦ Teach me
Cents kept per dollar of sales
Of every $1 of medicine sold, the cents left after the cost of making it (before R&D and marketing). Patent-protected drugs are cheap to manufacture relative to price, so the margin is high.
Wall Street calls this
Gross margin
An *82%* gross margin is the engine: it gives Lilly the cash to out-spend rivals on research *and* factories at the same time.
Drug economics · gross margin
82
%
Lilly keeps about 82¢ of every revenue dollar before overhead — even after prices fell this year. That's the cushion that funds everything else.
Source · 8-K · Item 2.02 — Operating Results (gross margin as a percent of revenue) · Q1 2026 · Filed Apr 30, 2026
An 82% margin means most new revenue drops toward the bottom line. So when sales jump 56%, profit jumps even more — the costs don't rise as fast as the sales. That's 'operating leverage,' and at Lilly's scale it's dramatic. Look at how much faster profit grew than revenue.
Operating leverage · operating income
$8.9
B
Operating profit grew 141% — more than twice as fast as revenue (+56%). Scale is turning each new sale into outsized profit.
So Lilly is wildly profitable. Where's the cash going? Not mostly to shareholders — into concrete. Demand for the shots has run ahead of Lilly's ability to make them, so it's building manufacturing plants around the world as fast as it can. The supply constraint, not demand, is what limits growth right now.
Racing to make more · capital spending
$7.8
B
Lilly spent $7.8B building factories in 2025 (up from ~$5B) and says spending will go *meaningfully higher* — the bottleneck is supply, not buyers.
Source · 10-K · MD&A — Liquidity and Capital Resources (capital expenditures) · FY2025 · Filed Feb 12, 2026
✓
Strong
82% margins, profit +141%; plowing $7.8B+ into factories to meet demand.